⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TXG News
10x Genomics, Inc. Class A Common Stock
10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group
prnewswire.com
TXG
Form 8-K
sec.gov
TXG
10x Genomics Reports First Quarter 2026 Financial Results
prnewswire.com
TXG
Form 8-K
sec.gov
TXG
Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsight
globenewswire.com
ADAG
ABBV
BIIB
BMRN
BLRX
CNSP
CYCN
GEN
GILD
GRAF
GSK
HSIC
HUBS
IBIO
INCY
JAZZ
JNJ
MAGN
MARA
MRK
NVS
OMER
PFE
PRGS
REGN
RGNX
SRPT
TENB
TGLS
TGTX
TNDM
TXG
VRTX
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference
prnewswire.com
TXG
The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms
prnewswire.com
TMDX
SENS
TXG
LiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic Advisor
businesswire.com
TXG
DHR
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
prnewswire.com
TXG
Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platform
businesswire.com
TXG
MBIO